Gene · 7033
Papers3,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression. | Cancers (Basel) | 2021 | 34068249 | PubTator, text mining | PubMed |
| Trefoil Factor Family (TFF) Peptides and Their Links to Inflammation: A Re-evaluation and New Medical Perspectives. | Int J Mol Sci | 2021 | 34066339 | PubTator, text mining | PubMed |
| Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes. | Cancers (Basel) | 2021 | 34066023 | PubTator, text mining | PubMed |
| Humulene Inhibits Acute Gastric Mucosal Injury by Enhancing Mucosal Integrity. | Antioxidants (Basel) | 2021 | 34064830 | PubTator, text mining | PubMed |
| Prevention Strategies for Esophageal Cancer-An Expert Review. | Cancers (Basel) | 2021 | 34062788 | PubTator, text mining | PubMed |
| The Promise of Tubule Biomarkers in Kidney Disease: A Review. | Am J Kidney Dis | 2021 | 34051308 | PubTator, text mining | PubMed |
| Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion-positive prostate cancer. | Clin Transl Med | 2021 | 34047472 | PubTator, text mining | PubMed |
| Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents. | Mol Cancer Ther | 2021 | 34045232 | PubTator, text mining | PubMed |
| Decreased GLUT2 and glucose uptake contribute to insulin secretion defects in MODY3/HNF1A hiPSC-derived mutant β cells. | Nat Commun | 2021 | 34035238 | PubTator, text mining | PubMed |
| LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer. | Cancer Res | 2021 | 34035083 | PubTator, text mining | PubMed |
| The role of epigenetic mechanisms in the regulation of gene expression in the cyclical endometrium. | Clin Epigenetics | 2021 | 34034824 | PubTator, text mining | PubMed |
| Gastrointestinal cancers in China, the USA, and Europe. | Gastroenterol Rep (Oxf) | 2021 | 34026216 | PubTator, text mining | PubMed |
| Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches. | Biomark Insights | 2021 | 34017167 | PubTator, text mining | PubMed |
| Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential. | Front Oncol | 2021 | 34012923 | PubTator, text mining | PubMed |
| A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer. | iScience | 2021 | 34007962 | PubTator, text mining | PubMed |
| Clinical features and prognostic factors in Covid-19: A prospective cohort study. | EBioMedicine | 2021 | 34000622 | PubTator, text mining | PubMed |
| Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction. | Circ Genom Precis Med | 2021 | 33999650 | PubTator, text mining | PubMed |
| Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine. | Genes Dis | 2021 | 33997160 | PubTator, text mining | PubMed |
| Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer. | Onco Targets Ther | 2021 | 33986602 | PubTator, text mining | PubMed |
| Intrachromosomal Amplification of Chromosome 21 in Childhood Acute Lymphoblastic Leukemia: Study of 3 Cases. | Case Rep Oncol | 2021 | 33976639 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7033/papers?page=50